title: Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients.
abstract: Obliterative bronchiolitis (OB) is the main cause of late mortality after lung transplantation. Cytomegalovirus infection has been associated with late graft failure. The aim of this study was to determine whether the development of OB was related to CMV pretransplant serological status and to CMV infections. The study group comprised 36 lung transplant recipients (27 HLT and 9 DLT) who survived more than 4 months, of whom 47% developed OB (defined by the persistence of an unexplained obstructive disease: FEV1/VC < 0.7). OB occurred more frequently: (1) in seronegative recipients with seropositive donors (8/9) than in seropositive recipients (7/19) or seronegative well-matched recipients (2/8); and (2) in patients who experienced CMV pneumonia (11/16) and CMV recurrence (11/16). Since matching seronegative recipients is the best way to prevent CMV infection, we believe that seronegative grafts must be reserved for seronegative recipients.
authors: Centre Chirurgical Marie Lannelongue, Plessis Robinson, France.
authors: J
authors: J
authors: Cerrina
authors: F
authors: F
authors: Le Roy Ladurie
authors: P H
authors: PH
authors: Herve
authors: F
authors: F
authors: Parquin
authors: S
authors: S
authors: Harari
authors: A
authors: A
authors: Chapelier
authors: G
authors: G
authors: Simoneau
authors: P
authors: P
authors: Vouhe
authors: P H
authors: PH
authors: Dartevelle
mesh_terms: D000293:Adolescent; D000328:Adult; D001989:Bronchiolitis Obliterans / Q000453:epidemiology; D002648:Child; D003586:Cytomegalovirus Infections / Q000453:epidemiology*; D005260:Female; D016041:Heart-Lung Transplantation / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D016040:Lung Transplantation / Q000009:adverse effects* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011024:Pneumonia, Viral / Q000453:epidemiology*; D011183:Postoperative Complications / Q000821:virology; D012129:Respiratory Function Tests